関連する実験動画
Updated: Jul 9, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
心不全の家庭での介入:再入院と生存に対する長期的な影響
Simon Stewart1, John D Horowitz
1Division of Health Sciences, University of South Australia. simon.stewart@unisa.edu.au
Circulation
|June 19, 2002
まとめ
慢性充血性心不全 (CHF) のための長期の家庭での介入は,再入院を大幅に減らし,生存率を改善します. これらの利益は持続し,多学科ケアプログラムの持続的な影響を示しています.
科学分野:
- 心臓病学 心臓病学
- ゲロントロジーはゲロントロジーの学科です.
- 公衆衛生は公衆衛生である.
背景:
- 慢性充血性心不全 (CHF) に対する退院後のプログラムの長期的な有効性は十分に確立されていません.
- イベントフリー生存,再入院,および医療費に対する介入の持続的な影響を評価することは極めて重要です.
研究 の 目的:
- CHF患者における多学科家庭内介入 (HBI) の長期的な効果を将来的に評価する.
- イベントフリー生存率,死亡率,再入院率,およびHBIと通常のケアとの関連コストを比較するために.
主な方法:
- HBI (n=149) または通常のケア (n=148) にランダムに割り当てられたCHF患者を含む前向きな研究.
- 追跡期間の中央値は4.2年でした.
- 予期せぬ再入院または死亡,生存期間,および医療費を含むプライマリエンドポイントの分析.
主要な成果:
- HBIグループでは,主要なイベント (計画外の再入院または死亡) が著しく少なく,HBIグループでは0.21対0.37イベント/患者/月;P<0.01) が発生しました.
- 平均的なイベントフリー生存期間は,HBI群で長かった (7対3ヶ月;P<0.01).
- HBIは,死亡率の減少 (56%対65%; P=0.06),生存期間の延長 (中位は40対22ヶ月; P<0.05),再入院の減少 (0.17対0.29/患者/月; P<0.05),およびより低い中位費用 ($A325対$A660/月; P<0.01) と関連していました.
結論:
- HBIの有益な効果は,CHF患者の計画外再入院を減らすことで,長期にわたって持続します.
- 自宅での介入は,CHF患者の生存期間を大幅に延長することと関連しています.
関連する概念動画
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...